Celldex Net Income from 2010 to 2024
| CLDX Stock | USD 37.77 1.08 2.78% |
Net Loss | First Reported 1990-03-31 | Previous Quarter -38.3 M | Current Value -43.3 M | Quarterly Volatility 15 M |
Check Celldex Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celldex main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 5.8 M or Selling General Administrative of 29.4 M, as well as many exotic indicators such as Price To Sales Ratio of 293, Dividend Yield of 0.0 or PTB Ratio of 3.62. Celldex financial statements analysis is a perfect complement when working with Celldex Therapeutics Valuation or Volatility modules.
Celldex | Net Income |
Latest Celldex Therapeutics' Net Income Growth Pattern
Below is the plot of the Net Income of Celldex Therapeutics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Celldex Therapeutics financial statement analysis. It represents the amount of money remaining after all of Celldex Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Celldex Therapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celldex Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (141.43 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Celldex Net Income Regression Statistics
| Arithmetic Mean | (92,295,103) | |
| Coefficient Of Variation | (47.36) | |
| Mean Deviation | 37,097,430 | |
| Median | (93,031,000) | |
| Standard Deviation | 43,708,319 | |
| Sample Variance | 1910.4T | |
| Range | 149.5M | |
| R-Value | (0.54) | |
| Mean Square Error | 1458.4T | |
| R-Squared | 0.29 | |
| Significance | 0.04 | |
| Slope | (5,273,682) | |
| Total Sum of Squares | 26745.8T |
Celldex Net Income History
Other Fundumenentals of Celldex Therapeutics
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Celldex Therapeutics Net Income component correlations
About Celldex Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Celldex Therapeutics income statement, its balance sheet, and the statement of cash flows. Celldex Therapeutics investors use historical funamental indicators, such as Celldex Therapeutics's Net Income, to determine how well the company is positioned to perform in the future. Although Celldex Therapeutics investors may use each financial statement separately, they are all related. The changes in Celldex Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Celldex Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Celldex Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Celldex Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -141.4 M | -134.4 M | |
| Net Loss | -124.6 M | -130.8 M | |
| Net Loss | -101.1 M | -106.1 M | |
| Net Loss | (2.92) | (3.07) | |
| Net Income Per E B T | 1.26 | 1.38 |
Pair Trading with Celldex Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Celldex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Celldex Stock
| 0.7 | VKTX | Viking Therapeutics Earnings Call Today | PairCorr |
| 0.73 | ENVB | Enveric Biosciences Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Celldex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Celldex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Celldex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Celldex Therapeutics to buy it.
The correlation of Celldex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Celldex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Celldex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Celldex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Celldex Therapeutics Correlation against competitors. For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.Note that the Celldex Therapeutics information on this page should be used as a complementary analysis to other Celldex Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Celldex Stock analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Celldex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celldex Therapeutics. If investors know Celldex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celldex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Revenue Per Share 0.142 | Quarterly Revenue Growth 1.561 | Return On Assets (0.22) | Return On Equity (0.37) |
The market value of Celldex Therapeutics is measured differently than its book value, which is the value of Celldex that is recorded on the company's balance sheet. Investors also form their own opinion of Celldex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Celldex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celldex Therapeutics' market value can be influenced by many factors that don't directly affect Celldex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celldex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Celldex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celldex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.